Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

Completed

Conditions studied: Human Immunodeficiency Viruses, Kidney Failure, HIV Infections

In brief

Tenofovir (TDF)-containing regimens may be associated with decreasing renal function in HIV-infected patients concurrently treated with boosted PI's and/or have co-morbid conditions including diabetes mellitus, hypertension, anemia, hepatitis B, and hepatitis C.

Key facts

Study ID

NCT00551655

Run by

AIDS Arms Inc.

People needed

684

Starts

2007-05-01

Expected to finish

2007-09-01

Last updated by the study team

2007-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV positive patients seen between 2003 and 2006

You may not qualify if…

• Fewer than two laboratory results

Where it is running

• Peabody Health Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.